Drugs / WJMSCs
WJMSCs
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT04313322 | Mar → Jun 2020 | — | Stem Cells Arabia | Unknown | No outcome recorded |
| Phase 22 trials | ||||||
| Phase 2 | NCT04551456 | Nov 2020 → Dec 2021 | coronary atherosclerosis | Navy General Hospital, Beijing | Unknown | No outcome recorded |
| Phase 2 | NCT01291329 | Feb 2011 → Feb 2012 | ST-elevation myocardial infarction | Navy General Hospital, Beijing | Completed | No outcome recorded |
| Comparator or background therapy2 trials | ||||||
| Phase 2 | NCT04551443 Comparator | Nov 2020 → Dec 2021 | acute myocardial infarction | Navy General Hospital, Beijing | Unknown | No outcome recorded |
| Phase 2 | NCT02368587 Comparator | Jan 2020 → Jan 2021 | cardiomyopathy | Navy General Hospital, Beijing | Unknown | No outcome recorded |
Evidence & citations 6 cited values
Every value below carries the sentence it was read from. 6 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | WJMSCs | “The investigators performed a double-blind, placebo- controlled trial, randomly assigning 300 patients with coronary artery disease to receive three times at 30-day intervals...” NCT04551456 ↗5“intracoronary infusion of WJ-MSCs or placebo medium into the infarct artery 4-7 days after successful reperfusion therapy.” NCT01291329 ↗ “Wharton's jelly-derived mesenchymal stem cells (WJMSCs), a primitive stromal population” PMID 26162993 ↗ Jul 2015 |
| Known as | Wharton's jelly-derived Mesenchymal Stem Cell | “The purpose of this study is to investigate the safety and efficacy of intracoronary or intravenous infusion human umbilical Wharton's jelly-derived Mesenchymal Stem Cell...” NCT02368587 ↗ |
| Known as | Wharton's jelly-derived mesenchymal stem cells | “Wharton's jelly-derived mesenchymal stem cells (WJMSCs), a primitive stromal population” PMID 26162993 ↗ Jul 2015 |
| Known as | WJMSC | “Therefore, in this randomized, controlled trial, our aim was to assess the safety and the anti-inflammatory efficacy of intravenous infusion human umbilical Wharton's...” NCT04551456 ↗1“The purpose of this study is to investigate the safety and efficacy of intracoronary or intravenous infusion human umbilical Wharton's jelly-derived Mesenchymal Stem Cell...” NCT02368587 ↗ |
| Modality | Cell therapy | “Wharton's jelly-derived Mesenchymal Stem Cell” NCT02368587 ↗ |
| Route | Other | “intracoronary infusion of WJ-MSCs or placebo medium into the infarct artery” NCT01291329 ↗ |